NCT02456480View on ClinicalTrials.gov

Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

37

Participants

Timeline

Start Date

May 31, 2015

Primary Completion Date

November 30, 2015

Study Completion Date

November 30, 2015

Conditions
Atopic Dermatitis
Interventions
DRUG

CLS001

topical gel

DRUG

Vehicle

topical gel

Trial Locations (1)

Unknown

Centre for Human Drug Research, Zernikedreef 8

All Listed Sponsors
lead

Maruho Co., Ltd.

INDUSTRY

NCT02456480 - Pharmacodynamics of Omiganan (CLS001) in Patients With Atopic Dermatitis | Biotech Hunter | Biotech Hunter